Aurora Biosciences Corporation designs, develops and commercializes proprietary drug discovery systems, services and technologies to accelerate and enhance the discovery of new medicines. Aurora is developing a proprietary, ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation and informatics. Aurora believes its integrated platform will shorten the time required to identify high quality lead compounds and to optimize those compounds into drug development candidates.